(Q34134811)

31 July 2017

1 reference

title

Anti-HIV effect of iron chelators: different mechanisms involved (English)

1 reference

31 July 2017

van Asbeck BS

1

1 reference

31 July 2017

Georgiou NA

2

1 reference

31 July 2017

van der Bruggen T

3

1 reference

31 July 2017

Oudshoorn M

4

1 reference

31 July 2017

Nottet HS

5

1 reference

31 July 2017

Marx JJ

6

1 reference

31 July 2017

publication date

1 February 2001

1 reference

Journal of Clinical Virology

31 July 2017

published in

1 reference

31 July 2017

volume

20

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

141-147

1 reference

A clinical review of bleomycin--a new antineoplastic agent

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Spectrum and Iron Content of Protein B2 from Ribonucleoside Diphosphate Reductase

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Site-specific cleavage of RNA by Fe(II).bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Oxygen radicals and human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Low levels of deoxynucleotides in peripheral blood lymphocytes: a strategy to inhibit human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

RNA degradation by bleomycin, a naturally occurring bioconjugate

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Design of orally active iron chelators

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Effect of iron deficiency and desferrioxamine on DNA synthesis in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Characterization of iron (II).bleomycin-mediated RNA strand scission

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Subcellular distribution of desferrioxamine and hydroxypyridin-4-one chelators in K562 cells affects chelation of intracellular iron pools

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

THE BIOCHEMISTRY OF DESFERRIOXAMINE AND ITS RELATION TO IRON METABOLISM

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Lack of effect of desferrioxamine on in-vitro HIV-1 replication.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Selective inhibition of l kappaB alpha phosphorylation and HIV-1 LTR-directed gene expression by novel antioxidant compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

The mechanism of the bleomycin-induced cleavage of DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Inhibition of ribonucleoside diphosphate reductase by 1-formylisoquinoline thiosemicarbazone and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Iron(II) Bleomycin-Mediated Degradation of a DNA-RNA Heteroduplex

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

An inducible transcription factor activates expression of human immunodeficiency virus in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Effect of orally active hydroxypyridinone iron chelators on human lymphocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Binding of bleomycin to DNA: intercalation of the bithiazole rings

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

A role for ferrous ion and oxygen in the degradation of DNA by bleomycin

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

Inhibition by desferrioxamine of in-vitro replication of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

1-year follow-up of the use of hydroxycarbamide and didanosine in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900122-0

7 January 2021

10.1016/S1386-6532(00)00122-0

Identifiers

DOI

1 reference

release_fwxjiamz35cjbppg4qvanbrnv4

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fwxjiamz35cjbppg4qvanbrnv4

24 November 2022

mapped directly with Wikidata item

1 reference